The Convergence 2021 Planning Committee is hard at work finalizing this year’s event. Be prepared to take on the challenges with the latest knowledge and vital updates in the regulatory field.

60 Sessions
60+ sessions across
four tracks
Biopharmaceuticals, Medical Devices,
IVDs and Business Acumen
Plenary Sessions
3 plenary sessions
streamed live online with chat,
Q&A functionality
Exclusive Sessions
Exclusive Sessions
only at Convergence
From solution providers and
global health authority organizations

 


 

Additional Elements of Convergence

 

Solutions Circles

Solutions Circles are back! These popular segments are where regulatory professionals gather to discuss and brainstorm on practices with the highest form of collaboration in mind, taking the knowledge collected through Convergence and use as think tanks. Bounce ideas off your colleagues. Examine regulatory challenges. Create and re-create learning structured by individuals who know the field best.

Dates and times for Solutions Circles will be available closer to the event.

Solution Circles

 

Group Rates

Interactive Activities

Convergence attendees work hard and play hard too! Enjoy a variety of engaging virtual activities throughout Convergence to help you decompress, unwind, and be recharged.

 

Meet the Authors

Hear directly from authors describing and introducing some of RAPS’ popular publications in an intimate forum where attendees can ask questions and share personal experiences.

Group Rates

 


 

CONVERGENCE 2021 PLANNING COMMITTEE

 

A special thank you to this year’s planning committee for cultivating an impressive line for this year’s event!

 

Meg Mucha

Chair, RAQA Executive, Quality Management System Medical Devices, IBM Watson Health

Kimberly Belsky
Kimberly Belsky

Vice Chair, Senior Director, Regulatory Intelligence, Mallinckrodt Pharmaceuticals

Gert Bos
Gert Bos

RAPS Board of Directors Representative, Executive Director and Partner, COS CEO Qserve China

Bassil Akra
Bassil Akra

Vice President Strategic Business Development, Global Medical Health Services, TÜV SÜD Product Service GmbH

Lisa Baumhardt
Lisa Baumhardt

Sr. Regulatory Affairs Manager of Global AI Strategy, IBM Watson Health

Anne Marie
Anne Marie

Finley President, Biotech Policy Group

Megha Deviprasad Iyer
Megha Deviprasad Iyer

Global Director, Regulatory Affairs, Thermo Fisher Scientific

Richard Jahn
Richard Jahn

Sr. Director Global Regulatory Policy & Intelligence, Global Product Development, Pfizer

Mac McKeen

Fellow, Regulatory Science, Boston Scientific

Kirsten Messmer
Kirsten Messmer

Principal Regulatory Affairs Specialist, PPD

Shereen Nennig
Shereen Nennig

Quality Assurance and Regulatory Affairs Professional

Erin Oliver
Erin Oliver

Head, US Regulatory Affairs, GlaxoSmithKline Consumer Healthcare

Maria Vrabie

Director, Regulatory & Clinical Affairs, Consumer Services & Products, Abbott Rapid Diagnostics

Carol Rehkopf

FDA Liaison, Deputy Associate Director for Review Management, CBER

Sabine Haubenreisser
Sabine Haubenreisser

EMA Liaison, Principal Scientific Administrator, Stakeholders and Communication Division, European Medicines Agency